We are live on ! Find out more
AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

51 hedge funds and large institutions have $12.6M invested in AVEO Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 11

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

7% less funds holding

Funds holding: 55 → 51 (-4)

23% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 13

41% less capital invested

Capital invested by funds: $21.4M → $12.6M (-$8.75M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $78K

Holders
51
Holders Change
-4
Holders Change %
-7.27%
% of All Funds
1.36%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
10
Increased
13
Reduced
11
Closed
13
Calls
–
Puts
$78K
Net Calls
-$78K
Net Calls Change
+$42K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$174K
2
GCM
Gruss Capital Management
New York
+$157K
3
Renaissance Technologies
Renaissance Technologies
New York
+$76.9K
4
VKH
Virtu KCG Holdings
New York
+$66.8K
5
SIM
Spark Investment Management
New York
+$57.1K

Top Sellers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
-$4.25M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$317K
3
PAI
Palo Alto Investors
California
-$264K
4
TC
TFS Capital
Pennsylvania
-$220K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$118K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Sarissa Capital Management
Connecticut
$2.16M – – –
BIT
2
BlackRock Institutional Trust
California
$1.87M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.54M +$174K +19,047 +12%
GCM
4
Gruss Capital Management
New York
$1.29M +$157K +17,200 +13%
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$711K +$15.1K +1,654 +2%
GIM
6
Granahan Investment Management
Massachusetts
$568K – – –
Renaissance Technologies
7
Renaissance Technologies
New York
$568K +$76.9K +8,410 +14%
DVC
8
Deer VI & Co
New York
$567K – – –
PAI
9
Palo Alto Investors
California
$562K -$264K -28,858 -30%
GX
10
Greylock XI
Massachusetts
$491K – – –
California Public Employees Retirement System
11
California Public Employees Retirement System
California
$354K – – –
Geode Capital Management
12
Geode Capital Management
Massachusetts
$314K +$283 +31 +0.1%
SIM
13
Spark Investment Management
New York
$156K +$57.1K +6,240 +50%
BCM
14
Bridgeway Capital Management
Texas
$151K – – –
USAA
15
United Services Automobile Association
Texas
$149K – – –
BFA
16
BlackRock Fund Advisors
California
$133K +$10.3K +1,129 +8%
Goldman Sachs
17
Goldman Sachs
New York
$116K -$52K -5,689 -29%
CC
18
Cannell & Co
New York
$99K -$29.9K -3,270 -22%
Northern Trust
19
Northern Trust
Illinois
$80K +$475 +52 +0.5%
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$79K -$12.9K -1,415 -13%
Tudor Investment Corp
21
Tudor Investment Corp
Connecticut
$74K -$10.2K -1,110 -11%
Jacobs Levy Equity Management
22
Jacobs Levy Equity Management
New Jersey
$72K -$118K -12,949 -60%
VKH
23
Virtu KCG Holdings
New York
$61K +$66.8K +7,308 New
Bank of New York Mellon
24
Bank of New York Mellon
New York
$56K +$46 +5 +0.1%
Millennium Management
25
Millennium Management
New York
$55K +$13.8K +1,513 +30%
1
2 3

AVEO Hedge Fund Activity: Q4 2014 in Review

51 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q4 2014, worth a combined $12.6M — down 41% from $21.4M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of AVEO and 10 opened new positions — a net loss of 3 holders — while 11 trimmed existing stakes and 13 added.

The largest buyer was Vanguard Group, adding an estimated $174K. The largest seller was Baupost Group, exiting entirely with an estimated $4.25M sold.

  • 51 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q4 2014, down from 55 in Q3 2014.
  • Funds reported $12.6M of AVEO Pharmaceuticals, Inc. stock for Q4 2014, down 41% quarter-over-quarter.
  • 10 funds opened new AVEO Pharmaceuticals, Inc. positions in Q4 2014 and 13 closed out, a net change of -3 holders.
  • The largest AVEO Pharmaceuticals, Inc. buyer in Q4 2014 was Vanguard Group, an estimated $174K added.
  • The largest AVEO Pharmaceuticals, Inc. seller in Q4 2014 was Baupost Group, an estimated $4.25M sold.

Based on aggregated 13F filings for Q4 2014.